I obtained my PhD training at the Spanish National Cancer Research Center (CNIO,Madrid) where my research focused on understanding the roles of RAS/MAPK signalling in developmental biology and tumorigenesis using genetically modified mouse models. Following my PhD, I joined the Growth Control and Metastasis Laboratory, at IRB Barcelona, to research genes and signalling pathways involved in colorectal cancer metastasis. I have joined AstraZeneca in 2018 where I am currently working as Associate Principal Scientist in the Small Molecule Bioscience team (Oncology R&D), leading preclinical data package generation to support clinical strategy and development of internal assets.